UPDATE 1-FDA approves AcuFocus' corneal implant

April 17, 2015 10:37 PM

3 0

April 17 (Reuters) - The U.S. Food and Drug Administration approved AcuFocus Inc's corneal implant to improve vision in patients with presbyopia, an age-related eye disorder.

The device, KAMRA inlay, is the first implantable device to correct vision in patients who have not had cataract surgery, the FDA said in a statement on Friday. (1.usa.gov/1Hh1g7V)

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page